pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European journal of pharmaceutics and biopharmaceutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/J.EJPB.2006.07.001PMID 16919924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Encyclopedia of Pharmaceutical Technology

  2006cited by this paper
• Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices.

  2005cited by this paper
• Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug.

  2005cited by this paper
• Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.

  2005cited by this paper
• pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP.

  2004cited by this paper
• Design of pH-independent controlled release matrix tablets for acidic drugs.

  2003cited by this paper
• The effect of beta-cyclodextrins on the permeation of diclofenac from supersaturated solutions.

  2003cited by this paper
• Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion.

  2003cited by this paper
• Evaluation of the new polyvinylacetate/ povidone excipient for matrix sustained release dosage forms

  2001cited by this paper
• Predicting the impact of physiological and biochemical processes on oral drug bioavailability.

  2001cited by this paper
• Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets.

  2000cited by this paper
• pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets.

  2000cited by this paper
• An organic acid-induced sigmoidal release system for oral controlled-release preparations. III. Elucidation of the anomalous drug release behavior through osmotic pumping mechanism

  1997cited by this paper
• Microenvironmental pH control of drug dissolution

  1989cited by this paper

• The revival of the mini-tablets: Recent advancements, classifications and expectations for the future.

  2025cites this paper
• Doxorubicin and ZnO-loaded gadolinium oxide hollow spheres for targeted cancer therapy and bioimaging.

  2025cites this paper
• Evaluating the Release of Different Commercial Orally Modified Niacin Formulations In Vitro

  2023cites this paper
• An Overview of Pharmaceutical Mini Tablet

  2022cites this paper
• Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

  2022cites this paper
• Enteric and hydrophilic polymers enhance dissolution and absorption of poorly soluble acidic drugs based on micro-environmental pH-modifying solid dispersion.

  2021cites this paper
• “ENHANCING TELMESARTAN BY USING SOLID DISPERSION TECHNIQUES”

  2021cites this paper
• Effects of Polyvinyl Alcohol on Drug Release from Nanocomposite Particles Using Poly (L-lactide-co-glycolide).

  2021cites this paper
• SUSTAINED RELEASE MATRIX TYPE DRUG DELIVERY SYSTEMS; A REVIEW

  2021cites this paper
• Effect of pH Modifiers on the Solubility, Dissolution Rate, and Stability of Telmisartan Solid Dispersions Produced by Hot-melt Extrusion Technology.

  2021cites this paper
• Exploration of isoxanthohumol bioconversion from spent hops into 8-prenylnaringenin using resting cells of Eubacterium limosum

  2020cites this paper
• A Wake-Up Call for the Efficient Use of the Bacterial Resting Cell Process, with Focus on Low Solubility Products

  2020cites this paper
• Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery.

  2020cites this paper
• Alkaline treatment for preventing acidosis in the rumen culture fermenting carbohydrates: An experimental study in vitro

  2019cites this paper
• Development and evaluation of dipyridamole sustained release tablets containing micro-environmental pH modifiers

  2019cites this paper
• Modulation of drug crystallization and molecular interactions by additives in solid dispersions for improving drug bioavailability.

  2019cites this paper
• Evaluation of the Enteric Performance of Lansoprazole Mini-Tabs Coated in a Perforated Pan

  2019cites this paper
• Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges.

  2019cites this paper
• Development of lipid matrix tablets containing a double fixed dose combination of artemisone and lumefantrine

  2018cites this paper
• The Influence of Aqueous Ethylcellulose Coating on the Performance of Hydrophilic Polyethylene Oxide Mini-Matrices Containing a Freely Water Soluble Drug

  2018cites this paper
• Tablet Formulation of a Polymeric Solid Dispersion Containing Amorphous Alkalinized Telmisartan

  2018cites this paper
• Design and Evaluation of Hydrophilic Matrix System for pH-Independent Sustained Release of Weakly Acidic Poorly Soluble Drug

  2018cites this paper
• Extended release of flurbiprofen from tromethamine-buffered HPMC hydrophilic matrix tablets

  2018cites this paper
• Development and in vitro evaluation of pH-independent release matrix tablet of weakly acidic drug valsartan using quality by design tools

  2018cites this paper
• Development and evaluation of self-nanoemulsifying drug delivery systems for oral delivery of indomethacin

  2018cites this paper
• Mini-Tablet Drug Delivery System for Pediatric Dosage Form (PDF): A Review of Manufacturing Perspectives

  2018cites this paper
• Mini Tablets: A Short Review-Revision

  2017cites this paper
• Impact of different organic acids on solubility enhancement of cefpodxime proxetil immediate release tablet and its stability studies.

  2017cites this paper
• Mini-tabs: Versatile Multiparticulate Option for Oral Drug Delivery

  2017cites this paper
• Investigation of Dissolution Behavior HPMC/Eudragit®/Magnesium Aluminometasilicate Oral Matrices Based on NMR Solid-State Spectroscopy and Dynamic Characteristics of Gel Layer

  2017cites this paper
• Formulation Development and Invitro Evaluation of Sustained Release Matrix Tablets of Nateglinide by Using Natural Polymers

  2017cites this paper
• Development of a liquid formulation of poorly water-soluble isosteviol sodium using the co-solvent technology

  2017cites this paper
• Formulation and evaluation of injectable in situ forming microparticles for sustained delivery of lornoxicam

  2017cites this paper
• Direct compaction: An update of materials, trouble-shooting, and application.

  2017cites this paper
• Formulation development and optimization: Encapsulated system of Atenolol and Glyburide.

  2016cites this paper
• Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2)

  2016cites this paper
• Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers

  2016cites this paper
• Methodology of oral formulation selection in the pharmaceutical industry.

  2016cites this paper
• Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1)

  2016cites this paper
• Development of polymer blend coatings for tailor-made drug release from solid dosage forms

  2015cites this paper
• Controlled release of acidic drugs in compendial and physiological hydrogen carbonate buffer from polymer blend-coated oral solid dosage forms.

  2015cites this paper
• Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups

  2015cites this paper
• Development of a compressed bead-in-capsule drug delivery system for sustained release

  2015cites this paper
• Design and evaluation of a specific, bi-phase extended release system based on differently coated mini-tablets.

  2015cites this paper
• In vitro dissolution and physicochemical characterizations of novel PVP-based solid dispersions containing valsartan prepared by a freeze-drying method.

  2014cites this paper
• Improved pH-dependent drug release and oral exposure of telmisartan, a poorly soluble drug through the formation of drug-aminoclay complex.

  2014cites this paper
• The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.

  2014cites this paper
• Gastroretentive floating systems - formulation development and in vitro evaluation

  2014cites this paper
• Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.

  2014cites this paper
• Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility

  2014cites this paper
• Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms

  2013cites this paper
• Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability.

  2012cites this paper
• Hot melt granulation: a facile approach for monolithic osmotic release tablets

  2012cites this paper
• OPTIMIZATION OF CLASS II BCS DRUG USING SOLID DISPERSION TECHNIQUE

  2012cites this paper
• optimization of class II BCS drug using solid dispersion technique

  2012cites this paper
• IMPROVEMENT OF DISSOLUTION CHARACTERISTICS AND BIOAVAILABILITY OF TADALAFIL BY SOLID DISPERSION TECHNIQUE USING WATER-SOLUBLE POLYMERS

  2012cites this paper
• OPTIMIZATION OF ACECLOFENAC ONCE DAILY MATRIX TABLETS: IN-VITRO AND IN-VIVO STUDIES

  2012cites this paper
• Excipients with specialized functions for effective drug delivery

  2012cites this paper
• OPTIMIZATION AND EVALUATION OF A FORMULATION CONTAINING LOW SOLUBLE ANTIHYPERTENSIVE AGENT Research Article

  2012cites this paper
• Application of FTIR spectroscopic imaging to study the effects of modifying the pH microenvironment on the dissolution of ibuprofen from HPMC matrices.

  2011cites this paper
• Sistemas multiparticulados: minicomprimidos

  2011cites this paper
• MASTER THESIS FOR THE DEGREE MASTER OF PHARMACY DEVELOPMENT OF CHITOSAN-COATED LIPOSOMES FOR IMPROVED THERAPY OF VAGINAL INFECTIONS: CLOTRIMAZOLE AS MODEL

  2011cites this paper
• Monitoring of internal pH gradients within multi-layer tablets by optical methods and EPR imaging.

  2011cites this paper
• DESIGN AND EVALUATION OF SUSTAINED RELEASE TABLET OF TELMISARTAN

  2011cites this paper
• Development of muds for improved vaginal therapy

  2011cites this paper
• Spectroscopic Imaging of the Compaction and Dissolution of Model Pharmaceutical Formulations

  2011cites this paper
• Composition pharmaceutique et forme galénique de l'élinogrel et leurs méthodes d'application

  2011cites this paper
• Matrix forming excipients from natural origin for controlled release matrix type tablets

  2011cites this paper
• Application of melt granulation technology using twin-screw extruder in development of high-dose modified-release tablet formulation.

  2011cites this paper
• Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid.

  2011cites this paper
• Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer

  2011cites this paper
• Roles of MgO release from polyethylene glycol 6000-based solid dispersions on microenvironmental pH, enhanced dissolution and reduced gastrointestinal damage of telmisartan

  2011cites this paper
• Evaluation of the impact of sodium lauryl sulfate source variability on solid oral dosage form development

  2010cites this paper
• The roles of acidifiers in solid dispersions and physical mixtures.

  2010cites this paper
• Design and in vitro evaluation of novel sustained-release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers

  2010cites this paper
• Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility

  2010cites this paper
• Formulation and optimization of osmotically controlled release tablets of glipizide: hot melt granulation.

  2010cites this paper
• Biopharmaceutic Consideration and Assessment for Oral Controlled Release Formulations

  2010cites this paper
• The suitability of tris(hydroxylmethyl) aminomethane (THAM) as a buffering system for hydroxypropyl methylcellulose (HPMC) hydrophilic matrices containing a weak acid drug.

  2010cites this paper
• Insulin-Loaded Nanoparticles Based on N-Trimethyl Chitosan: In Vitro (Caco-2 Model) and Ex Vivo (Excised Rat Jejunum, Duodenum, and Ileum) Evaluation of Penetration Enhancement Properties

  2010cites this paper
• Oral Extended-Release Formulations

  2010cites this paper
• pH modulation: a mechanism to obtain pH-independent drug release

  2010influential citation
• Improved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersion

  2010cites this paper
• Composition solide pour liberation controlee d'agents actifs ionisables avec une faible solubilite aqueuse a ph bas, et procedes d'utilisation associes

  2009cites this paper
• Mechanisms of drug release in citrate buffered HPMC matrices.

  2009cites this paper
• Physicochemical characterization of solid dispersions prepared using hot-melt extrusion technology

  2009cites this paper
• Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug.

  2009cites this paper
• Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release.

  2008cites this paper
• Extended-release oral drug delivery technologies: monolithic matrix systems.

  2008cites this paper
• Formulation Variables Influencing Drug Release from Layered Matrix System Comprising Chitosan and Xanthan Gum

  2008cites this paper
• Effect of Particle Size of Chitosan on Drug Release from Layered Matrix System Comprising Chitosan and Xanthan Gum

  2008cites this paper
• İN-VİTRO ÇÖZÜNÜRLÜK ÇALIŞMALARININ BİLGİSAYARLA TAKİBİ, KONTROLU, TAHMİNİ VE VALİDASYONU

  2007cites this paper
• The effect of pH and Polymer type on Release of Diltiazem HCl from hydrophilic matrices

  2007cites this paper